Live Breaking News & Updates on Vertex Pharmaceuticals Profile

Stay updated with breaking news from Vertex pharmaceuticals profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bellevue Group AG Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […] ....

Brucei Sachs , Reshma Kewalramani , Piper Sandler , News Ratings For Vertex Pharmaceuticals Daily , Insider Transactions At Vertex Pharmaceuticals , Canaccord Genuity Group , Securities Exchange Commission , Vertex Pharmaceuticals Profile , Wolfe Research , Bellevue Group , Telos Capital Management Inc , Quarter For Vertex Pharmaceuticals , Investment Management , Cantor Fitzgerald , Exchange Commission , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals , Sherbrooke Park Advisers , Vertex Pharmaceuticals Stock , Morgan Stanley , Free Report , Park Advisers , Capital Management , Grey Street Capital , Street Capital , Director Bruce ,

Bellevue Group AG Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […] ....

Reshma Kewalramani , Brucei Sachs , Piper Sandler , Canaccord Genuity Group , Telos Capital Management Inc , Cantor Fitzgerald , Quarter For Vertex Pharmaceuticals , Sherbrooke Park Advisers , Vertex Pharmaceuticals Stock , Insider Transactions At Vertex Pharmaceuticals , Vertex Pharmaceuticals , Securities Exchange Commission , Exchange Commission , News Ratings For Vertex Pharmaceuticals Daily , Investment Management , Vertex Pharmaceuticals Incorporated , Bellevue Group , Morgan Stanley , Wolfe Research , Vertex Pharmaceuticals Profile , Free Report , Park Advisers , Capital Management , Grey Street Capital , Street Capital , Director Bruce ,

Stamos Capital Partners L.P. Trims Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Stamos Capital Partners L.P. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 56.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,240 shares of the pharmaceutical company’s stock after selling 1,630 shares […] ....

Ourania Tatsis , Brucei Sachs , Vertex Pharmaceuticals Profile , News Ratings For Vertex Pharmaceuticals Daily , Arthurm Cohen Associates , Vertex Pharmaceuticals , Vertex Pharmaceuticals Stock Performance , Quarter For Vertex Pharmaceuticals , Securities Exchange Commission , Royal Bank , Canaccord Genuity Group , Exchange Commission , Venturi Wealth Management , Hohimer Wealth Management , Nicholas Hoffman Company , Vertex Pharmaceuticals Incorporated , Johnson Financial Group Inc , Free Report , Wealth Management , Financial Group , Pharmaceuticals Incorporated , Get Free Report , Director Bruce , Genuity Group , Vertex Pharmaceuticals Daily ,

Rhenman & Partners Asset Management AB Acquires 18,500 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Rhenman & Partners Asset Management AB grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 24.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 95,000 shares of the pharmaceutical company’s stock after purchasing an additional […] ....

Reshma Kewalramani , Charlesf Wagner Jr , Oppenheimer Co , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals , Quarter For Vertex Pharmaceuticals , Securities Inc , Kestra Private Wealth Services , Wolfe Research , Vertex Pharmaceuticals Profile , Vertex Pharmaceuticals Trading , Royal Bank , News Ratings For Vertex Pharmaceuticals Daily , Insider Activity At Vertex Pharmaceuticals , Exchange Commission , Summit Financial , Partners Asset Management , Free Report , Private Wealth Services , Pharmaceuticals Incorporated , Get Free Report , Visit Holdingschannel , Vertex Pharmaceuticals Daily ,

Parnassus Investments LLC Buys 74 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Parnassus Investments LLC grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 11.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 738 shares of the pharmaceutical company’s stock after purchasing an additional 74 shares during the period. Parnassus Investments LLC’s […] ....

Brucei Sachs , Carmen Bozic , Piper Sandler , William Blair , News Ratings For Vertex Pharmaceuticals Daily , Vanguard Group Inc , Morgan Stanley , Needham Company , Wells Fargo Company , Northern Trust Corp , Vertex Pharmaceuticals Profile , Quarter For Vertex Pharmaceuticals , Vertex Pharmaceuticals Price Performance , Vertex Pharmaceuticals , Norges Bank , Jennison Associates , Securities Exchange Commission , Vertex Pharmaceuticals Incorporated , Exchange Commission , Royal Bank , Parnassus Investments , Free Report , Trust Corp , Director Bruce , Pharmaceuticals Incorporated , Get Free Report ,